SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001017491-18-000103
Filing Date
2018-10-31
Accepted
2018-10-31 16:33:32
Documents
63
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q apri9301810q.htm 10-Q 1078851
2 EXHIBIT 31.1 apri93018ex311.htm EX-31.1 11897
3 EXHIBIT 32.1 apri93018ex321.htm EX-32.1 5898
  Complete submission text file 0001017491-18-000103.txt   5898516

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT apri-20180930.xml EX-101.INS 842736
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apri-20180930.xsd EX-101.SCH 67371
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apri-20180930_cal.xml EX-101.CAL 58885
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apri-20180930_def.xml EX-101.DEF 365269
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apri-20180930_lab.xml EX-101.LAB 710364
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apri-20180930_pre.xml EX-101.PRE 492212
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22245 | Film No.: 181150754
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences